IP Library › Granted Patent US 8,431,597
Granted Patent B2
US 8,431,597 · App. 13/404,169 · Granted Apr 30, 2013

Benzimidazole derivatives

Inventors: Michael J. Munchhof (Salem, CT); Lawrence A. Reiter (Mystic, CT); Susan D. La Greca (Old Lyme, CT); Christopher S. Jones (Gales Ferry, CT); Qifang Li (Stonington, CT)
Assignee: Pfizer Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,431,597
App. No.
13/404,169
Granted
Apr 30, 2013
Kind
B2
Abstract

The present invention relates to a compound of the Formula I or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3A , R 3B , R 4 , R 5 , X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

Claims (2)

1. A pharmaceutical composition, comprising a compound which is

or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient.

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →
Continuity (4)
Continuation 12142119 · Jun 19, 2008
Provisional Application 60947287 · Jun 29, 2007
Provisional Application 61041645 · Apr 2, 2008
Related Publication 20120157495A1 · Jun 21, 2012